Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
527,262,232
-
Share change
-
-31,463,428
-
Total reported value
-
$5,557,830,830
-
Put/Call ratio
-
165%
-
Price per share
-
$10.54
-
Number of holders
-
257
-
Value change
-
-$345,239,824
-
Number of buys
-
156
-
Number of sells
-
96
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q1 2024
As of 31 Mar 2024 Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) had 257 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 527,262,232 shares of stock of the company.
Largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, QVT Financial LP, BlackRock Inc., MORGAN STANLEY, FMR LLC, Rubric Capital Management LP, STATE STREET CORP, Patient Square Capital LP, and Woodline Partners LP.
This table shows 258 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.